Market Overview

Trade RXN stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
11/23/18Credit SuisseAssumesOutperformNeutral31.0
10/10/18OppenheimerMaintainsOutperformOutperform37.0
10/03/18Goldman SachsInitiates Coverage OnNeutral0.0

Earnings View Earnings

Q2 2019 EST Actual Surprise
EPS: 0.42 0.46 0.04
Rev: 515.69M 524.80M 9.11M
Q3 2019 EST Actual Surprise
EPS: Expected
2019-01-30
Rev:

Company Profile